http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#Head http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#assertion http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#provenance http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#pubinfo http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#assertion http://purl.obolibrary.org/obo/DOID_0060185 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_0060185 http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00512 http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association http://www.w3.org/2000/01/rdf-schema#label vancomycin hydrochloride for injection usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin resistant b lactam resistant staphylococci it is indicated for penicillin allergic patients for patients who cannot receive or who have failed to respond to other drugs including the penicillins or cephalosporins and for infections caused by vancomycin susceptible organisms that are resistant to other antimicrobial drugs vancomycin hydrochloride for injection usp is indicated for initial therapy when methicillin resistant staphylococci are suspected but after susceptibility data are available therapy should be adjusted accordingly vancomycin hydrochloride for injection usp is effective in the treatment of staphylococcal endocarditis its effectiveness has been documented in other infections due to staphylococci including septicemia bone infections lower respiratory tract infections skin and skin structure infections when staphylococcal infections are localized and purulent antibiotics are used as adjuncts to appropriate surgical measures vancomycin hydrochloride for injection usp has been reported to be effective alone or in combination with an aminoglycoside for endocarditis caused by s viridans or s bovis for endocarditis caused by enterococci e g e faecalis vancomycin hydrochloride has been reported to be effective only in combination with an aminoglycoside vancomycin hydrochloride for injection usp has been reported to be effective for the treatment of diphtheroid endocarditis vancomycin hydrochloride for injection usp has been used successfully in combination with either rifampin an aminoglycoside or both in early onset prosthetic valve endocarditis caused by s epidermidis or diphtheroids specimens for bacteriologic cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin to reduce the development of drug resistant bacteria and maintain the effectiveness of vancomycin hydrochloride for injection usp and other antibacterial drugs vancomycin hydrochloride for injection usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy the parenteral form of vancomycin hydrochloride may be administered orally for treatment of antibiotic associated pseudomembranous colitis produced by c difficile and for staphylococcal enterocolitis parenteral administration of vancomycin hydrochloride alone is of unproven benefit for these indications vancomycin is not effective by the oral route for other types of infection http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00512 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#provenance http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#pubinfo http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#sig http://purl.org/nanopub/x/hasSignature RuNIFQdJxUqwcPJJK//wmrrrkPkxuGDdaWsYH66rVkYki2IKNfC0sP8X9UQk69yKvi4JLDkxS/ZX022iZJA2W308zlrfOT+fIsYfyziL6sk0lbktJG5P8k3h5y4mqFeWCXerKyQvlSZRmspx+4FJi769QESj7Clne7eA16LYY5Y= http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y http://purl.org/dc/terms/created 2021-06-27T21:13:22.272+02:00 http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA7H1rninwqim52mbK17k7vE5ni8FMbg_I4VsBAfD6G4Y https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs